November 23, 2024 – Dr. Jamie Ghossein, CEO of Cannabis Orchards Inc., has been appointed as a Director of the Canadian Hemp Trade Alliance (CHTA) for a two-year term. Dr. Ghossein participated at the CHTA annual meeting in Montreal, where he shared groundbreaking advancements in cannabinoid hemp breeding and genetics development. His presentation, titled “Research and Advancements in Hemp Genetics and Breeding,” highlighted Cannabis Orchards’ pioneering work in the cannabinoid sector and its potential to advance health and therapeutic applications.
“At Cannabis Orchards, we are dedicated to advancing hemp genetics and breeding with a focus on therapeutic cannabinoids, which hold tremendous promise for health applications,” said Dr. Ghossein. “As a physician, I am particularly passionate about the therapeutic potential of cannabinoids and the critical role they can play in modern medicine. Joining the CHTA as a Director allows me to contribute not only as an industry partner, but also as a health advocate and researcher, working to bridge the gap between industry, research, regulation, and patient care.”
As a newly appointed Director, Dr. Ghossein will leverage his dual expertise in medicine and hemp research to help the CHTA shape research priorities, establish rigorous standards for cannabinoid hemp, and advocate for health-focused innovations. His role includes engaging with regulatory bodies such as Health Canada, Agriculture Canada, the Canadian Food Inspection Agency (CFIA), and the Canadian Seed Growers’ Association (CSGA) to drive policy and regulatory alignment that supports the therapeutic potential of hemp-derived cannabinoids.
Cannabis Orchards, a young and dynamic company, has earned recognition for its cutting-edge contributions to the hemp industry, particularly in the minor cannabinoid sector. The company integrates advanced molecular biology with traditional breeding techniques to develop innovative solutions that benefit patients, researchers, and the broader Cannabis community.
Dr. Ghossein’s leadership reflects a commitment to advancing hemp’s role in medicine and public health, reinforcing Canada’s position as a global leader in hemp research and innovation. His appointment as a CHTA Director underscores the critical intersection of agriculture, science, and health advocacy in shaping the future of the hemp industry.
About Cannabis Orchards Inc.:
Cannabis Orchards Inc. specializes in industrial hemp research and development, focusing on breeding high-quality hemp genetics and advancing the cannabinoid sector. The company partners with cultivators, processors, and academic researchers to deliver innovative solutions that address both agricultural and health needs.
Media Contact:
Rachael Cranston
Media Relations
Cannabis Orchards Inc.
Commentaires